Cigna (CI) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $298.81, +3.19% vs the prior close of $289.58.
- Volume 2.07M shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CI jumps 3.2% to $298.81, a 1-month high. Closed at $298.81, +3.19% vs the prior close of $289.58. Day range $292.47–$300.11, opened at $293.50.
CI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CI jumps 3.2% to $298.81, a 1-month high
- Closed at $298.81, +3.19% vs the prior close of $289.58. Day range $292.47–$300.11, opened at $293.50.
- Volume was 2.07M shares, 1.3x its 50-day average of 1.61M.
- Price is +7.3% vs its 50-day average ($278.38) and +6.6% vs its 200-day average ($280.30).
- 52-week range $239.51–$311.34; today's close sits at 83% of that range, 4.0% below the 52-week high.
Oct 14, 2026 — CI rises 2.5% to $289.58, a 1-month high
- Closed at $289.58, +2.50% vs the prior close of $282.53. Day range $283.56–$290.08, opened at $283.85.
- Volume was 1.40M shares, 0.9x its 50-day average of 1.64M.
- Price is +4.2% vs its 50-day average ($277.81) and +3.4% vs its 200-day average ($280.19).
- 52-week range $239.51–$311.34; today's close sits at 70% of that range, 7.0% below the 52-week high.
Oct 13, 2026 — CI ends flat (-0.3%) to $282.53
- Closed at $282.53, -0.29% vs the prior close of $283.34. Day range $277.43–$289.35, opened at $287.20.
- Volume was 1.54M shares, 0.9x its 50-day average of 1.64M.
- Price is +1.8% vs its 50-day average ($277.50) and +0.9% vs its 200-day average ($280.12).
- 52-week range $239.51–$311.34; today's close sits at 60% of that range, 9.3% below the 52-week high.
Oct 12, 2026 — CI rises 0.3% to $283.34, 7 up days in a row
- Closed at $283.34, +0.32% vs the prior close of $282.43. Day range $281.36–$285.55, opened at $283.36.
- Volume was 970.60K shares, 0.6x its 50-day average of 1.67M — lighter than usual.
- Price is +2.1% vs its 50-day average ($277.49) and +1.2% vs its 200-day average ($280.08).
- 52-week range $239.51–$311.34; today's close sits at 61% of that range, 9.0% below the 52-week high.
- That makes 7 straight gains.
Oct 9, 2026 — CI rises 0.5% to $282.43, 6 up days in a row
- Closed at $282.43, +0.50% vs the prior close of $281.03. Day range $280.46–$287.89, opened at $281.16.
- Volume was 885.40K shares, 0.5x its 50-day average of 1.70M — lighter than usual.
- Price is +1.8% vs its 50-day average ($277.40) and +0.9% vs its 200-day average ($280.03).
- 52-week range $239.51–$312.18; today's close sits at 59% of that range, 9.5% below the 52-week high.
- That makes 6 straight gains.
- SEC filings that day: 8-K.
Oct 8, 2026 — CI rises 0.9% to $281.03, 5 up days in a row
- Closed at $281.03, +0.90% vs the prior close of $278.51. Day range $275.32–$282.42, opened at $278.98.
- Volume was 1.55M shares, 0.9x its 50-day average of 1.70M.
- Price is +1.3% vs its 50-day average ($277.51) and +0.4% vs its 200-day average ($280.00).
- 52-week range $239.51–$312.18; today's close sits at 57% of that range, 10.0% below the 52-week high.
- That makes 5 straight gains.
Oct 7, 2026 — CI rises 1.5% to $278.51, 4 up days in a row
- Closed at $278.51, +1.51% vs the prior close of $274.37. Day range $274.76–$283.13, opened at $274.88.
- Volume was 1.63M shares, 1.0x its 50-day average of 1.70M.
- Price is +0.2% vs its 50-day average ($277.82) and -0.5% vs its 200-day average ($279.95).
- 52-week range $239.51–$312.18; today's close sits at 54% of that range, 10.8% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — CI rises 1.1% to $274.37, 3 up days in a row
- Closed at $274.37, +1.14% vs the prior close of $271.29. Day range $270.00–$275.82, opened at $271.72.
- Volume was 1.09M shares, 0.6x its 50-day average of 1.71M.
- Price is -1.4% vs its 50-day average ($278.27) and -2.0% vs its 200-day average ($279.93).
- 52-week range $239.51–$312.18; today's close sits at 48% of that range, 12.1% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — CI ends flat (+0.3%) to $271.29
- Closed at $271.29, +0.28% vs the prior close of $270.53. Day range $266.46–$273.11, opened at $270.00.
- Volume was 1.54M shares, 0.9x its 50-day average of 1.70M.
- Price is -2.6% vs its 50-day average ($278.60) and -3.1% vs its 200-day average ($279.93).
- 52-week range $239.51–$315.47; today's close sits at 42% of that range, 14.0% below the 52-week high.
Oct 2, 2026 — CI rises 1.0% to $270.53
- Closed at $270.53, +0.96% vs the prior close of $267.96. Day range $266.00–$271.40, opened at $270.03.
- Volume was 1.91M shares, 1.1x its 50-day average of 1.68M.
- Price is -3.0% vs its 50-day average ($278.97) and -3.4% vs its 200-day average ($279.95).
- 52-week range $239.51–$315.47; today's close sits at 41% of that range, 14.2% below the 52-week high.
CI latest news & SEC filings
Every SEC filing by or about CI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 8, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Neville Everett sold 617 shares at $284.05 (≈$175.26K) on Sep 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 20, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 20, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Jones Nicole S sold 2,677 shares at $279.61 (≈$748.52K) on Aug 18, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 30, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $71.67B (prior year $67.18B) (+6.7% vs Jun 30, 2025)
- Net income: $1.66B (prior year $1.53B) (+8.4% vs Jun 30, 2025)
- Diluted EPS: $6.29 (prior year $5.71) (+10.2% vs Jun 30, 2025)
Jul 30, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 24, 2026 · 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade CI
- Last results release: Jul 30, 2026 (8-K Item 2.02). Previous ones: Apr 30, 2026, Feb 5, 2026, Oct 30, 2025. Based on that rhythm, the next report is likely around Oct 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.09% (largest 3.2%).
- Liquidity: about 1.69M shares (≈$505.62M) trade per day on average.
- 52-week position: $298.81 vs a range of $239.51–$311.34 (83% of the range).
- Dividends: last ex-dividend date Sep 8, 2026 ($1.56/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 20 sales; latest: Everett Neville sold 617 shares on Sep 3, 2026.
- Latest filings: 8-K Oct 9, 2026; 8-K Sep 30, 2026; 10-Q Jul 30, 2026.
- Share count: 264.24M shares outstanding (Jul 24, 2026), -1.0% vs a year earlier.
- Listing: NYSE · industry: Hospital & Medical Service Plans.
CI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 293.50 | 300.11 | 292.47 | 298.81 | 2.07M |
| Oct 14, 2026 | 283.85 | 290.08 | 283.56 | 289.58 | 1.40M |
| Oct 13, 2026 | 287.20 | 289.35 | 277.43 | 282.53 | 1.54M |
| Oct 12, 2026 | 283.36 | 285.55 | 281.36 | 283.34 | 970.60K |
| Oct 9, 2026 | 281.16 | 287.89 | 280.46 | 282.43 | 885.40K |
| Oct 8, 2026 | 278.98 | 282.42 | 275.32 | 281.03 | 1.55M |
| Oct 7, 2026 | 274.88 | 283.13 | 274.76 | 278.51 | 1.63M |
| Oct 6, 2026 | 271.72 | 275.82 | 270.00 | 274.37 | 1.09M |
| Oct 5, 2026 | 270.00 | 273.11 | 266.46 | 271.29 | 1.54M |
| Oct 2, 2026 | 270.03 | 271.40 | 266.00 | 270.53 | 1.91M |
| Oct 1, 2026 | 275.97 | 275.97 | 262.85 | 267.96 | 1.98M |
| Sep 30, 2026 | 274.03 | 278.88 | 263.36 | 271.83 | 3.08M |
| Sep 29, 2026 | 269.97 | 276.61 | 269.01 | 275.26 | 1.98M |
| Sep 28, 2026 | 272.48 | 272.49 | 269.05 | 271.83 | 1.75M |
| Sep 25, 2026 | 266.13 | 273.36 | 265.35 | 272.01 | 1.82M |
| Sep 24, 2026 | 267.90 | 269.33 | 263.76 | 265.50 | 1.61M |
| Sep 23, 2026 | 273.26 | 274.75 | 267.02 | 268.27 | 1.83M |
| Sep 22, 2026 | 276.85 | 278.47 | 272.73 | 273.74 | 1.47M |
| Sep 21, 2026 | 275.91 | 275.91 | 272.62 | 274.47 | 1.39M |
| Sep 18, 2026 | 274.86 | 277.72 | 273.74 | 275.28 | 2.33M |
About Cigna
Cigna (CI) is listed on the NYSE and classified by the SEC under “Hospital & Medical Service Plans”. Its business address is in BLOOMFIELD, CT. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1739940.
CI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David Cordani | Chairman & CEO | May 14, 2026 |
| Eric J Foss | Director | Apr 24, 2026 |
| Neesha Hathi | Director | Apr 24, 2026 |
| Michael J Hennigan | Director | Apr 24, 2026 |
| George Kurian | Director | Sep 2, 2026 |
| Kathleen M Mazzarella | Director | Apr 24, 2026 |
| Mark B. Mcclellan | Director | Apr 24, 2026 |
| Philip Ozuah | Director | Apr 24, 2026 |
| Kimberly A. Ross | Director | Apr 24, 2026 |
| Eric C Wiseman | Director | Apr 24, 2026 |
| Donna F Zarcone | Director | Apr 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Cordani | Chairman & CEO | May 14, 2026 |
| Ann M Dennison | EVP, CFO | Mar 3, 2026 |
| Brian C Evanko | See Remarks | Sep 3, 2026 |
| Bryan Holgerson | See Remarks | Aug 20, 2026 |
| Nicole S Jones | See Remarks | Aug 20, 2026 |
| Jamie G Kates | Chief Accounting Officer | Jun 16, 2026 |
| Adam Kautzner | See Remarks | Jul 9, 2026 |
| Durga Prasad Koka | EVP, Global CIO | Jun 3, 2026 |
| Andrea L Nelson | EVP, General Counsl & Corp Sec | Apr 3, 2026 |
| Everett Neville | See Remarks | Sep 8, 2026 |
| Matthew Perlberg | See Remarks | Jul 9, 2026 |
| Jason D Sadler | See Remarks | Jul 9, 2026 |
| Paul A Sanford | See Remarks | Jul 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Everett Neville | Sale | 617 | $284.05 |
| Aug 18, 2026 | Nicole S Jones | Sale | 2,677 | $279.61 |
| Aug 4, 2026 | Nicole S Jones | Sale | 19,436 | $276.27 |
| Jun 12, 2026 | Jamie G Kates | Sale | 899 | $298.61 |
| May 12, 2026 | David Cordani | Sale | 3,903 | $286.83 |
| May 12, 2026 | David Cordani | Sale | 14,292 | $287.96 |
| May 12, 2026 | David Cordani | Sale | 13,839 | $288.85 |
| May 12, 2026 | David Cordani | Sale | 41,099 | $290.00 |
| May 12, 2026 | David Cordani | Sale | 13,732 | $291.01 |
| May 12, 2026 | David Cordani | Sale | 12,315 | $291.95 |
| May 12, 2026 | David Cordani | Sale | 7,861 | $292.88 |
| May 12, 2026 | David Cordani | Sale | 2,142 | $293.92 |
| May 12, 2026 | David Cordani | Sale | 38,487 | $294.98 |
| May 12, 2026 | David Cordani | Sale | 34,641 | $295.98 |
| May 12, 2026 | David Cordani | Sale | 2,017 | $296.84 |
CI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $274.90B | $5.96B | 22.18 | $9.60B |
| Dec 31, 2024 | $247.12B | $3.43B | 12.12 | $10.36B |
| Dec 31, 2023 | $195.26B | $5.16B | 17.39 | $11.81B |
| Dec 31, 2022 | $180.52B | — | 21.41 | $8.66B |
| Dec 31, 2021 | $174.07B | — | 15.75 | $7.19B |
Latest balance sheet: total assets $157.08B, total liabilities $114.17B, cash $6.30B (as of Jun 30, 2026).
CI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 30, 2026 | 8-K Item 2.02 (results) | $287.66 |
| Apr 30, 2026 | 8-K Item 2.02 (results) | $290.58 |
| Feb 5, 2026 | 8-K Item 2.02 (results) | $284.53 |
| Oct 30, 2025 | 8-K Item 2.02 (results) | $247.10 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $267.38 |
| May 2, 2025 | 8-K Item 2.02 (results) | $334.75 |
| Jan 30, 2025 | 8-K Item 2.02 (results) | $282.98 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $314.81 |
| Aug 1, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 2, 2024 | 8-K Item 2.02 (results) | — |
| Nov 2, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Hospital & Medical Service Plans
UnitedHealth (UNH)Elevance Health (ELV)Humana (HUM)Centene (CNC)Oscar Health (OSCR)Molina Healthcare (MOH)Alignment Healthcare (ALHC)Clover Health Investments (CLOV)Trupanion (TRUP)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.